FTDZX Mutual Fund

NAV$184.69

Returns Overview

1 Month
+3.25%
3 Months
+1.81%
6 Months
+42.10%
YTD
+4.11%
1 Year
+55.65%
3 Years
+26.01%
5 Years
+7.61%
10 Years
+14.37%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FTDZX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

No data

3 Months Performance

No data

6 Months Performance

No data

1 Year Performance

No data

Benchmark & Peers

Benchmark
NASDAQ Biotechnology Index(^NBI)
This Mutual Fund (YTD)
+4.11%
Peer Avg (YTD)
+1.55%
vs Peers
+2.56%

FTDZX Mutual Fund Performance

FTDZX performance across multiple time periods: 1-month 3.25%, YTD 4.11%, 1-year 55.65%, 3-year 26.01%, 5-year 7.61%, 10-year 14.37%.

FTDZX returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.77%, investors should weigh costs against performance when evaluating this mutual fund.

FTDZX performance comparison shows side-by-side returns with another fund. FTDZX alternatives are available in the Mutual Fund Screener.